Women’s health and reproductive healthcare are undergoing a major shift toward non-hormonal, non-invasive therapeutic options. Driven by an increasing awareness of the side effects associated with legacy hormonal therapies, global healthcare providers and biopharma developers are prioritizing novel non-hormonal contraceptive mechanisms. According to deep-dive industry research on the...